Beta blockers
Beta blockers now have stronger data in heart       failure than converting enzyme inhibitors, and should be considered standard       therapy in mild-moderate heart failure.
 @SUBJECT$  now have stronger data  @PREDICAT$   @OBJECT$  than converting enzyme inhibitors, and should be considered standard       therapy in mild-moderate heart failure.